Spectrazyme, 180 count, 60 count, 12 bottles/case, 20000 tablets/box, 14000 capsules/pail.

FDA recall notice · announced November 20, 2013 · Metagenics

Class II FDA/FSIS Class II: use may cause temporary or medically reversible adverse health consequences.

The product

Reason for recall

Metagenics is recalling Spectrazyme because their raw material supplier informed them that enzymes in the blend may contain the antibiotic chloramphenicol.

Notes

Distribution: Nationwide in US and worldwide to Japan, Taiwan, Belgium, and Canada
Lot/code information: Lot Code: 0413083 0513007 0513008
Quantity: 1,171,300 units
Status: Terminated
Products in this recall event:
- Spectrazyme, 180 count, 60 count, 12 bottles/case, 20000 tablets/box, 14000 capsules/pail. (F-0138-2014)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.